The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and participating NIH Institutes are offering this grant to advance the critical field of pediatric drug development. This initiative focuses on addressing the research needs for creating appropriate drug formulations for different pediatric age groups, ensuring medications are safe and effective for children. Additionally, this grant encourages the development and rigorous testing of novel drug delivery systems specifically designed for the unique physiology of the pediatric population. This funding is for the purpose of complementing and significantly accelerating ongoing efforts, deliberately avoiding duplication with the private sector, to ensure children receive optimal and age-appropriate therapeutic interventions.
Opportunity ID: 242013
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-13-345 |
| Funding Opportunity Title: | Development of Appropriate Pediatric Formulations and Drug Delivery Systems (R43) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health Income Security and Social Services |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.173 — Research Related to Deafness and Communication Disorders |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Sep 06, 2013 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Sep 07, 2016 |
| Current Closing Date for Applications: | Sep 07, 2016 |
| Archive Date: | Oct 08, 2016 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $150,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and participating Institutes within the National Institutes of Health (NIH) encourage grant applications to address different and complementary research needs for the development of appropriate pediatric drug formulations in different age groups. This FOA also encourages the development and testing of novel drug delivery systems in the pediatric population. The goal of this FOA is not to duplicate or compete with the private sector but to complement and accelerate the development of appropriate pediatric drugs formulations and drug delivery systems. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-13-345.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| ADOBE-FORMS-B2 | ADOBE-FORMS-B2 | PKG00184850 | Nov 05, 2013 | Jan 07, 2015 | View | |
| FORMS-C | Use for due dates on or after August 5, 2014 | PKG00196571 | Nov 05, 2013 | Jun 08, 2016 | View | |
| FORMS-D | Use for due dates on or after May 25, 2016 | PKG00224092 | Aug 05, 2016 | Sep 07, 2016 | View |
Package 1
Mandatory forms
242013 RR_SF424_1_2-1.2.pdf
242013 PerformanceSite_1_4-1.4.pdf
242013 RR_OtherProjectInfo_1_3-1.3.pdf
242013 RR_KeyPersonExpanded_1_2-1.2.pdf
242013 RR_Budget-1.1.pdf
242013 PHS398_CoverPageSupplement_1_4-1.4.pdf
242013 PHS398_ResearchPlan_1_3-1.3.pdf
242013 PHS398_Checklist_1_3-1.3.pdf
242013 SBIR_STTR_Information_1_1-1.1.pdf
Optional forms
242013 RR_SubawardBudget30-1.2.pdf
242013 PHS_CoverLetter_1_2-1.2.pdf
Package 2
Mandatory forms
242013 RR_SF424_2_0-2.0.pdf
242013 PHS398_ResearchPlan_2_0-2.0.pdf
242013 SBIR_STTR_Information_1_1-1.1.pdf
242013 RR_KeyPersonExpanded_2_0-2.0.pdf
242013 RR_OtherProjectInfo_1_3-1.3.pdf
242013 RR_Budget_1_3-1.3.pdf
242013 PerformanceSite_2_0-2.0.pdf
242013 PHS398_CoverPageSupplement_2_0-2.0.pdf
Optional forms
242013 RR_SubawardBudget30_1_3-1.3.pdf
242013 PlannedReport-1.0.pdf
242013 PHS398_CumulativeInclusionReport-1.0.pdf
Package 3
Mandatory forms
242013 RR_SF424_2_0-2.0.pdf
242013 PHS398_CoverPageSupplement_3_0-3.0.pdf
242013 RR_OtherProjectInfo_1_3-1.3.pdf
242013 PerformanceSite_2_0-2.0.pdf
242013 RR_KeyPersonExpanded_2_0-2.0.pdf
242013 RR_Budget_1_3-1.3.pdf
242013 PHS398_ResearchPlan_3_0-3.0.pdf
242013 SBIR_STTR_Information_1_1-1.1.pdf
Optional forms
242013 RR_SubawardBudget30_1_3-1.3.pdf
242013 PHS_Inclusion_Enrollment_Report-1.0.pdf
242013 PHS_AssignmentRequestForm-1.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
